Merja Roivainen
Enterovirus Laboratory
National Public Health Institute
Mannerheimintie 166
FIN-00300 Helsinki
Finland
Name/email consistency: high
- A whole cell immunization-derived monoclonal antibody that protects cells from coxsackievirus A9 infection binds to both cell surface and virions. Roivainen, M., Alakulppi, N., Ylipaasto, P., Eskelinen, M., Paananen, A., Airaksinen, A., Hovi, T. J. Virol. Methods (2005)
- Functional impairment and killing of human beta cells by enteroviruses: the capacity is shared by a wide range of serotypes, but the extent is a characteristic of individual virus strains. Roivainen, M., Ylipaasto, P., Savolainen, C., Galama, J., Hovi, T., Otonkoski, T. Diabetologia (2002)
- Screening enteroviruses for beta-cell tropism using foetal porcine beta-cells. Roivainen, M., Ylipaasto, P., Ustinov, J., Hovi, T., Otonkoski, T. J. Gen. Virol. (2001)
- Mechanisms of coxsackievirus-induced damage to human pancreatic beta-cells. Roivainen, M., Rasilainen, S., Ylipaasto, P., Nissinen, R., Ustinov, J., Bouwens, L., Eizirik, D.L., Hovi, T., Otonkoski, T. J. Clin. Endocrinol. Metab. (2000)
- Several different enterovirus serotypes can be associated with prediabetic autoimmune episodes and onset of overt IDDM. Childhood Diabetes in Finland (DiMe) Study Group. Roivainen, M., Knip, M., Hyöty, H., Kulmala, P., Hiltunen, M., Vähäsalo, P., Hovi, T., Akerblom, H.K. J. Med. Virol. (1998)









